Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas
MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma
